Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
Public ClinicalTrials.gov record NCT00233402. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to document the additional detection of papillary bladder cancer and the reduced early recurrence due to the improved detection and resection of these tumors after Hexvix cystoscopy compared to standard cystoscopy in patients with papillary bladder cancer.
Study identification
- NCT ID
- NCT00233402
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 789 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Jun 30, 2008
- Completion
- Jul 31, 2008
- Last update posted
- Oct 10, 2013
2005 – 2008
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Cancer Center, Department of Urology | Stanford | California | 94305-5820 | — |
| V.A. Medical Center | Gainesville | Florida | 32608 | — |
| University of Miami School of Medicine | Miami | Florida | 33136 | — |
| South Florida Clinical Research Center, Inc. | Pembroke Pines | Florida | 33028 | — |
| The Emory Clinic, Dept of Urology | Atlanta | Georgia | 30322 | — |
| Boston University School of Medicine | Boston | Massachusetts | 02118 | — |
| St. Joseph Mercy Hospital- Ann Arbor | Ann Arbor | Michigan | 48106 | — |
| Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Mount Sinai Medical Center, Department of Urology | New York | New York | 10029-6574 | — |
| URMC | Rochester | New York | 14642 | — |
| Urological Institute at Beachwood Cleveland Clinic | Beachwood | Ohio | 44120 | — |
| Thomas Jefferson Medical College, Department of Neurology | Philadelphia | Pennsylvania | 19107 | — |
| Vanderbilt University Medical Center, Department of Urologic Surgery | Nashville | Tennessee | 37232-2765 | — |
| Baylor College of Medicine, Scott Department of Urology | Houston | Texas | 77030-2726 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
Recently updated Bladder Cancer trials
Other public records listing Bladder Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07781852: Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer Not yet recruiting
- NCT07762586: Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC) Recruiting
- NCT06963346: Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents Recruiting
- NCT07732686: Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry Not yet recruiting
- NCT07660055: Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors Recruiting
- NCT07646847: A Study of a Side Effects and Resource Navigation Program for People With Cancer Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00233402, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2013 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00233402 live on ClinicalTrials.gov.